Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Baxter
Deloitte
QuintilesIMS
Accenture
Federal Trade Commission

Generated: July 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,231,961

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,231,961 protect, and when does it expire?

Patent 10,231,961 protects GOPRELTO and is included in one NDA.

Summary for Patent: 10,231,961
Title:Pharmaceutical compositions and methods of using the same
Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
Inventor(s): Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA)
Assignee: GENUS LIFESCIENCES INC. (Allentown, PA)
Application Number:15/434,014
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 10,231,961
Patent Claim Types:
see list of patent claims
Composition; Formulation;

Drugs Protected by US Patent 10,231,961

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genus Lifesciences GOPRELTO cocaine hydrochloride SOLUTION;NASAL 209963-001 Dec 14, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Cipla
Federal Trade Commission
Express Scripts
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.